openPR Logo
Press release

Global End-Stage Renal Disease Market Size-Forecasts to 2026

Global End-Stage Renal Disease Market

Global End-Stage Renal Disease Market

As per the research conducted by GME, the Global End-Stage Renal Disease Market is projected to grow from USD 74.01 billion in 2021 to USD 144.09 billion by 2026 at a CAGR value of 12.1%. The end-stage renal disease (ESRD) market is predicted to be driven by a spike in the number of kidney failure sufferers and the development of technologically improved medical devices and equipment such as minimal dialysis equipment and artificial kidneys.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global End-Stage Renal Disease Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/end-stage-renal-disease-market-3345

By Disease Type (Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Failure) By Treatment (Transplant, Dialysis [Peritoneal Dialysis, Hemodialysis, Wearable Artificial Kidney]), By Region (North America, Europe, Asia Pacific, MEA, and CSA), End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Key Market Insights
• As per the type of disease, CKD will be the fastest growing segment because it is one of the key causes of the rising number of kidney failure patients
• The dialysis sector holds the largest share of the market during the forecast period
• In 2020, Asia Pacific dominated the ESRD market based on the CAGR value and is analyzed to maintain this trend
• According to the Global Burden of Disease Study, 697.55 million cases with all-stage CKD were observed in 2018, with a global prevalence of 91%
• Nipro Corporation; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; Medtronic Plc; B. Braun Melsungen AG; BD; Abbott Laboratories, Asahi Kasei Medical Co., Ltd.; Cantel Medical; Nikkiso Co., Ltd.; JMS Co. Ltd. are the major players in the end-stage renal disease market..

Browse the Report @ https://www.globalmarketestimates.com/market-report/end-stage-renal-disease-market-3345

Disease Type Outlook (Revenue, USD Billion, 2021-2026)
• Chronic Kidney Disease
• End-Stage Renal Disease (ESRD)
• Kidney Failure

Treatment Outlook (Revenue, USD Billion, 2021-2026)
• Transplant
• Dialysis
• Peritoneal Dialysis
• Hemodialysis
• Wearable Artificial Kidney

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global End-Stage Renal Disease Market Size-Forecasts to 2026 here

News-ID: 2321949 • Views:

More Releases from Global Market Estimates Research & Consultants

Global Flare Monitoring Market Size & Trends
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029. Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market Insights • As per
Global Fiber Optic Component System Market Size & Trends
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029. Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market
Global Rechargeable Battery Market Size & Trends
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029. Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded
Global Asset Management Solution Market Size & Trends
Global Asset Management Solution Market Size & Trends
According to a new market research report published by Global Market Estimates, the global asset management solution market is projected to grow at a CAGR of 35.1% from 2024 to 2029. The growth of the global asset management solution market is driven by increasing demand for efficient and automated asset tracking and management, the growing need for compliance and risk management in various industries (IoT), and the expanding adoption of cloud-based

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and